GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
+20.29%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$374M
AUM Growth
+$374M
Cap. Flow
+$47.3M
Cap. Flow %
12.64%
Top 10 Hldgs %
44.45%
Holding
75
New
29
Increased
7
Reduced
10
Closed
22
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LJPC
51
DELISTED
La Jolla Pharmaceutical Company
LJPC
-200,000
Closed -$6.44M
CELG
52
DELISTED
Celgene Corp
CELG
0
ZGNX
53
DELISTED
Zogenix, Inc.
ZGNX
-180,000
Closed -$7.21M
JUNO
54
DELISTED
Juno Therapeutics, Inc.
JUNO
-150,000
Closed -$6.86M
ABLX
55
DELISTED
Ablynx NV American Depositary Shares
ABLX
-90,000
Closed -$2.25M
HZNP
56
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-400,000
Closed -$5.84M
ARRY
57
DELISTED
Array Biopharma Inc
ARRY
-500,000
Closed -$6.4M
DERM
58
DELISTED
Dermira, Inc.
DERM
-100,000
Closed -$2.78M
PTLA
59
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-225,000
Closed -$11M
AIMT
60
DELISTED
Aimmune Therapeutics, Inc.
AIMT
-158,200
Closed -$5.98M
GNMK
61
DELISTED
GenMark Diagnostics, Inc
GNMK
-500,000
Closed -$2.09M
ALXN
62
DELISTED
Alexion Pharmaceuticals Inc
ALXN
-115,000
Closed -$13.8M
XLRN
63
DELISTED
Acceleron Pharma Inc.
XLRN
-200,000
Closed -$8.49M
GBT
64
DELISTED
Global Blood Therapeutics, Inc.
GBT
-325,000
Closed -$12.8M
XBI icon
65
SPDR S&P Biotech ETF
XBI
$5.29B
0
RYTM icon
66
Rhythm Pharmaceuticals
RYTM
$6.75B
-25,000
Closed -$727K
RIGL icon
67
Rigel Pharmaceuticals
RIGL
$710M
-825,000
Closed -$3.2M
NTLA icon
68
Intellia Therapeutics
NTLA
$1.26B
-175,000
Closed -$3.36M
IRTC icon
69
iRhythm Technologies
IRTC
$5.67B
-65,000
Closed -$3.64M
INCY icon
70
Incyte
INCY
$17B
-50,000
Closed -$4.74M
FXB icon
71
Invesco CurrencyShares British Pound Sterling Trust
FXB
$90.4M
-9,100
Closed -$1.19M
ESPR icon
72
Esperion Therapeutics
ESPR
$490M
-230,000
Closed -$15.1M
EDIT icon
73
Editas Medicine
EDIT
$225M
-65,000
Closed -$2M
CRSP icon
74
CRISPR Therapeutics
CRSP
$4.82B
-150,000
Closed -$3.52M
BMY icon
75
Bristol-Myers Squibb
BMY
$96.7B
0